Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

First patient in treatment in RhoVac's clinical phase IIb study in Sweden

prnasiaSeptember 18, 2020

Tag: RhoVac AB , Prostate Cancer , BRaVac

PharmaSources Customer Service